Defining the range of pathogens susceptible to ifitm3 restriction using a knockout mouse model

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Everitt, Aaron R ^a   Clare, Simon ^a   McDonald, Jacqueline U ^b   Kane, Leanne ^a   Harcourt, Katherine ^a   Ahras, Malika ^a   Lall, Amar ^c   Hale, Christine ^a   Rodgers, Angela ^d   Young, Douglas B ^d   Haque, Ashraful ^e   Billker, Oliver ^a   Tregoning, John S ^b   Dougan, Gordon ^a   Kellam, Paul ^a,f  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^e QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FRAGILIS PROTEIN, MOUSE; MEMBRANE PROTEIN;

ANIMAL; ANIMAL MODEL; BACTERIA; C57BL MOUSE; CITROBACTER RODENTIUM; DEFICIENCY; GROWTH, DEVELOPMENT AND AGING; HOMEOSTASIS; HUMAN RESPIRATORY SYNCYTIAL VIRUS; KINETICS; KNOCKOUT MOUSE; MALARIA; METABOLISM; MYCOBACTERIUM TUBERCULOSIS; PARASITOLOGY; PHENOTYPE; PHYSIOLOGY; PLASMODIUM BERGHEI; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM;

ANIMALS; BACTERIA; CITROBACTER RODENTIUM; HOMEOSTASIS; KINETICS; MALARIA; MEMBRANE PROTEINS; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, ANIMAL; MYCOBACTERIUM TUBERCULOSIS; PHENOTYPE; PLASMODIUM BERGHEI; RESPIRATORY SYNCYTIAL VIRUSES; SALMONELLA TYPHIMURIUM;

EID: 84894247386     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080723     Document Type: Article

References (51)

1. Takeuchi O, Akira S (2010) Pattern Recognition Receptors and Inflammation. Cell 140: 805-820. doi:10.1016/j.cell.2010.01.022. PubMed: 20303872.
2. Akira S, Uematsu S, Takeuchi O (2006) Pathogen Recognition and Innate Immunity. Cell 124: 783-801. doi:10.1016/j.cell.2006.02.015. PubMed: 16497588.
3. Diamond MS, Farzan M (2013) The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nat Rev Immunol 13: 46-57. PubMed: 23237964.
4. Tanaka SS, Yamaguchi YL, Tsoi B, Lickert H, Tam PPL (2005) IFITM/mil/fragilis family proteins IFITM1 and IFITM3 play distinct roles in mouse primordial germ cell homing and repulsion. Dev Cell 9: 745-756. doi:10.1016/j.devcel.2005.10.010. PubMed: 16326387.
5. Feeley EM, Sims JS, John SP, Chin CR, Pertel T et al. (2011) IFITM3 Inhibits Influenza A Virus Infection by Preventing Cytosolic Entry. PLoS Pathog 7: e1002337. PubMed: 22046135.
6. Everitt AR, Clare S, Pertel T, John SP, Wash RS et al. (2012) IFITM3 restricts the morbidity and mortality associated with influenza. Nature 484: 519-523. doi:10.1038/nature10921. PubMed: 22446628.
7. Brass AL, Huang IC, Benita Y, John SP, Krishnan MN et al. (2009) The IFITM Proteins Mediate Cellular Resistance to Influenza A H1N1 Virus, West Nile Virus, and Dengue Virus. Cell 139: 1243-1254. doi:10.1016/j.cell.2009.12.017. PubMed: 20064371.
8. Huang IC, Bailey CC, Weyer JL, Radoshitzky SR, Becker MM et al. (2011) Distinct Patterns of IFITM-Mediated Restriction of Filoviruses, SARS Coronavirus, and Influenza A Virus. PLoS Pathog 7: 13. PubMed: 21253575.
9. Anafu AA, Bowen CH, Chin CR, Brass AL, Holm GH (2013) Interferon Inducible Transmembrane Protein 3 (IFITM3) Restricts Reovirus Cell Entry. J Biol Chem.
10. Weidner JM, Jiang D, Pan XB, Chang JH, Block TM et al. (2010) Interferon-Induced Cell Membrane Proteins, IFITM3 and Tetherin, Inhibit Vesicular Stomatitis Virus Infection via Distinct Mechanisms. J Virol 84: 12646-12657. doi:10.1128/JVI.01328-10. PubMed: 20943977.
11. Jiang D, Weidner JM, Qing M, Pan XB, Guo HT et al. (2010) Identification of Five Interferon-Induced Cellular Proteins That Inhibit West Nile Virus and Dengue Virus Infections. J Virol 84: 8332-8341. doi:10.1128/JVI.02199-09. PubMed: 20534863.
12. Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT et al. (2011) A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472: 481-U545. doi:10.1038/nature09907. PubMed: 21478870.
13. Mudhasani R, Tran JP, Retterer C, Radoshitzky SR, Kota K et al. (2013) Ifitm-2 and Ifitm-3 but Not Ifitm-1 Restrict Rift Valley Fever. Virus - J Virol.
14. Wilkins C, Woodward J, Lau DTY, Barnes A, Joyce M et al. (2013) IFITM1 is a tight junction protein that inhibits hepatitis C virus entry. Hepatology 57: 461-469. doi:10.1002/hep.26066. PubMed: 22996292.
15. John SP, Chin CR, Perreira JM, Feeley EM, Aker AM et al. (2013) The CD225 Domain of IFITM3 is Required for both IFITM Protein Association and Inhibition of Influenza A Virus and Dengue Virus Replication. J Virol, 87: 7837-52. PubMed: 23658454.
16. Amini-Bavil-Olyaee S, Choi Youn ÂJ, Lee Jun ÂH, Shi M, Huang IC et al. (2013) The Antiviral Effector IFITM3 Disrupts Intracellular Cholesterol Homeostasis to Block Viral Entry. Cell Host and Microbe 13: 452-464. doi:10.1016/j.chom.2013.03.006. Available online at: doi:10.1016/j.chom.2013. 03.006
17. Chandran K, Farsetta DL, Nibert ML (2002) Strategy for Nonenveloped Virus Entry: a Hydrophobic Conformer of the Reovirus Membrane Penetration Protein Î1/41 Mediates Membrane Disruption. J Virol 76: 9920-9933. doi:10.1128/JVI.76.19.9920-9933.2002. PubMed: 12208969.
18. Wiethoff CM, Wodrich H, Gerace L, Nemerow GR (2005) Adenovirus protein VI mediates membrane disruption following capsid disassembly. J Virol 79: 1992-2000. doi:10.1128/JVI.79.4.1992-2000.2005. PubMed: 15681401.
19. Zhang Y-H, Zhao Y, Li N, Peng Y-C, Giannoulatou E et al. (2013) Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals. Nat Commun 4: 1418. doi:10.1038/ncomms2433. PubMed: 23361009.
20. Sharma S, DeOliveira RB, Kalantari P, Parroche P, Goutagny N et al. (2011) Innate Immune Recognition of an AT-Rich Stem-Loop DNA Motif in the Plasmodium falciparum Genome. Immunity 35: 194-207. doi:10.1016/j.immuni.2011. 05.016. PubMed: 21820332.
21. Shen C, Wu X-r, Jiao W-w, Sun L, Feng W-x et al. (2013) A Functional Promoter Polymorphism of 〈italic〉IFITM3〈/italic〉 Is Associated with Susceptibility to Pediatric Tuberculosis in Han Chinese. Population - PLOS ONE 8: e67816. doi:10.1371/journal.pone.0067816.
22. Lange UC, Adams DJ, Lee C, Barton S, Schneider R et al. (2008) Normal germ line establishment in mice carrying a deletion of the Ifitm/Fragilis gene family cluster. Mol Cell Biol 28: 4688-4696. doi:10.1128/MCB.00272-08. PubMed: 18505827.
23. Ayadi A, Birling MC, Bottomley J, Bussell J, Fuchs H et al. (2012) Mouse large-scale phenotyping initiatives: overview of the European Mouse Disease Clinic (EUMODIC) and of the Wellcome Trust Sanger Institute Mouse Genetics Project. Mamm Genome 23: 600-610. doi:10.1007/s00335-012-9418-y. PubMed: 22961258.
24. White Jacqueline ÂK, Gerdin A-K, Karp Natasha ÂA, Ryder E, Buljan M et al. (2013) Genome-wide Generation and Systematic Phenotyping of Knockout Mice Reveals New Roles for Many. Genes. Cells 154: 452-464.
25. Franke-Fayard B, Janse CJ, Cunha-Rodrigues M, Ramesar J, Büscher P et al. (2005) Murine malaria parasite sequestration: CD36 is the major receptor, but cerebral pathology is unlinked to sequestration. Proc Natl Acad Sci U S A 102: 11468-11473. doi:10.1073/pnas.0503386102. PubMed: 16051702.
26. Carroll RW, Wainwright MS, Kim KY, Kidambi T, Gomez ND et al. (2010) A rapid murine coma and behavior scale for quantitative assessment of murine cerebral malaria. PLOS ONE 5.
27. Yamaguchi Y, Harker JA, Wang B, Openshaw PJ, Tregoning JS et al. (2012) Preexposure to CpG protects against the delayed effects of neonatal respiratory syncytial virus infection. J Virol 86: 10456-10461. doi:10.1128/JVI.01082-12. PubMed: 22811525.
28. de Oca MM, Engwerda C, Haque A (2013) Plasmodium berghei ANKA (PbA) infection of C57BL/6J mice: a model of severe malaria. Methods Mol Biol 1031: 203-213. doi:10.1007/978-1-62703-481-4-23. PubMed: 23824903.
29. Wee YS, Roundy KM, Weis JJ, Weis JH (2012) Interferon-inducible transmembrane proteins of the innate immune response act as membrane organizers by influencing clathrin and v-ATPase localization and function. Innate Immun 18: 834-845. doi:10.1177/1753425912443392. PubMed: 22467717.
30. Dandekar T, Fieselmann A, Popp J, Hensel M (2012) Salmonella enterica: A surprisingly well adapted intracellular lifestyle. Frontiers - Int Microbiology 3.
31. Mundy R, MacDonald TT, Dougan G, Frankel G, Wiles S (2005) Citrobacter rodentium of mice and man. Cell Microbiol 7: 1697-1706. doi:10.1111/j.1462-5822. 2005.00625.x. PubMed: 16309456.
32. Clare S, John V, Walker AW, Hill JL, Abreu-Goodger C et al. (2013) Enhanced Susceptibility to Citrobacter rodentium Infection in MicroRNA-155-Deficient Mice. Infect Immun 81: 723-732. doi:10.1128/IAI.00969-12. PubMed: 23264052.
33. Flynn JL, Chan J (2001) Immunology of tuberculosis. Annu Rev Immunol 19: 93-129. doi:10.1146/annurev.immunol.19.1.93. PubMed: 11244032.
34. Novikov A, Cardone M, Thompson R, Shenderov K, Kirschman KD et al. (2011) Mycobacterium tuberculosis triggers host type I IFN signaling to regulate IL-1beta production in human macrophages. J Immunol 187: 2540-2547. doi:10.4049/jimmunol.1100926. PubMed: 21784976.
35. Hunt NH, Grau GE (2003) Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol 24: 491-499. doi:10.1016/S1471-4906(03)00229-1. PubMed: 12967673.
36. Haque A, Best SE, Ammerdorffer A, Desbarrieres L, de Oca MM et al. (2011) Type I interferons suppress CD4(+) T-cell-dependent parasite control during blood-stage Plasmodium infection. Eur J Immunol 41: 2688-2698. doi:10.1002/eji.201141539. PubMed: 21674481.
37. Ball EA, Sambo M.Rr., Martins M, Trovoada MJ, Benchimol C et al. (2013) IFNAR1 Controls Progression to Cerebral Malaria in Children and CD8+ T Cell Brain Pathology in Plasmodium berghei-Infected Mice. The Journal of Immunology 190: 5118-5127.
38. Bailey CC, Huang IC, Kam C, Farzan M (2012) Ifitm3 Limits the Severity of Acute Influenza in Mice. PLoS Pathog 8: 11. PubMed: 22969429.
39. Tregoning JS, Yamaguchi Y, Wang B, Mihm D, Harker JA et al. (2010) Genetic Susceptibility to the Delayed Sequelae of Neonatal Respiratory Syncytial Virus Infection Is MHC Dependent. J Immunol 185: 5384-5391. doi:10.4049/jimmunol.1001594. PubMed: 20921522.
40. Stark JM, McDowell SA, Koenigsknecht V, Prows DR, Leikauf JE et al. (2002) Genetic susceptibility to respiratory syncytial virus infection in inbred mice. J Med Virol 67: 92-100. doi:10.1002/jmv.2196. PubMed: 11920822.
41. Tregoning JS, Schwarze Jr (2010) Respiratory Viral Infections in Infants: Causes, Clinical Symptoms, Virology, and Immunology. Clin Microbiol Rev 23: 74-98. doi:10.1128/CMR.00032-09. PubMed: 20065326.
42. Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM et al. (2009) The Burden of Respiratory Syncytial Virus Infection in Young. Children - New England Journal of Medicine 360: 588-598. doi:10.1056/NEJMoa0804877.
43. Janssen R, Pennings J, Hodemaekers H, Buisman A, van Oosten M et al. (2007) Host Transcription Profiles upon Primary Respiratory Syncytial Virus. Infection - Journal of Virology 81: 5958-5967. doi:10.1128/JVI.02220-06.
44. Pennings JLA, Schuurhof A, Hodemaekers HM, Buisman A, de Rond LCGH et al. (2011) Systemic Signature of the Lung Response to Respiratory Syncytial Virus. Infection - PLOS ONE 6: e21461. doi:10.1371/journal.pone.0021461.
45. Ioannidis I, McNally B, Willette M, Peeples ME, Chaussabel D et al. (2012) Plasticity and Virus Specificity of the Airway Epithelial Cell Immune Response during Respiratory Virus. Infection - Journal of Virology 86: 5422-5436. doi:10.1128/JVI.06757-11.
46. Bucasas KL, Mian AI, Demmler-Harrison GJ, Caviness AC, Piedra PA et al. (2013) Global gene expression profiling in infants with acute respiratory syncytial virus broncholitis demonstrates systemic activation of interferon signaling networks. Pediatr Infect Dis J 32: e68-e76. doi:10.1097/INF. 0b013e318278b4b3. PubMed: 23190772.
47. San-Juan-Vergara H, Sampayo-Escobar V, Reyes N, Cha B, Pacheco-Lugo L et al. (2012) Cholesterol-rich microdomains as docking platforms for respiratory syncytial virus in normal human bronchial epithelial cells. J Virol 86: 1832-1843. doi:10.1128/JVI.06274-11. PubMed: 22090136. Available online at: doi:10.1128/JVI.06274-11 Available online at: PubMed: 22090136
48. Lay MK, González PA, León MA, Céspedes PF, Bueno SM et al. (2013) Advances in understanding respiratory syncytial virus infection in airway epithelial cells and consequential effects on the immune response. Microbes Infect 15: 230-242. doi:10.1016/j.micinf.2012.11.012. PubMed: 23246463.
49. Li K, Markosyan RM, Zheng YM, Golfetto O, Bungart B et al. (2013) IFITM proteins restrict viral membrane hemifusion. PLoS Pathog 9: e1003124. PubMed: 23358889.
50. Jia R, Pan Q, Ding S, Rong L, Liu SL et al. (2012) The N-terminal region of IFITM3 modulates its antiviral activity by regulating IFITM3 cellular localization. J Virol 86: 13697-13707. doi:10.1128/JVI.01828-12. PubMed: 23055554.
51. Ravi LI, Li L, Sutejo R, Chen H, Wong PS et al. (2013) A systemsbased approach to analyse the host response in murine lung macrophages challenged with respiratory syncytial virus. BMC Genomics 14: 190. doi:10.1186/1471-2164-14- 190. PubMed: 23506210.